SRC Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human SRC. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human SRC. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 36 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, bindingdb, ccds, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, mim, orphanet, ortholog, paralog, pdb, pharmgkb, pharmgkb_gene, reactome, refseq, scxa, signor, spliceai, string_interaction, transcript, uniprot
Generated: 2026-03-29 — For the latest data, query BioBTree directly via MCP or API.
View API calls (49)
SRC

SRC Gene: Complete Identifier and Functional Mapping Reference ╔═══════════════════════════════════════════════════════════════════════════════╗ ║ ║ ║ ███████╗██████╗ ██████╗ ║ ║ ██╔════╝██╔══██╗██╔════╝ ║ ║ ███████╗██████╔╝██║ ║ ║ ╚════██║██╔══██╗██║ ║ ║ ███████║██║ ██║╚██████╗ ║ ║ ╚══════╝╚═╝ ╚═╝ ╚═════╝ ║ ║ ║ ║ Proto-oncogene tyrosine-protein kinase Src ║ ║ Cross-Database Identifier & Functional Mapping Reference ║ ║ ║ ╚═══════════════════════════════════════════════════════════════════════════════╝


Section 1: Gene Identifiers Primary Gene Identifiers

DatabaseIdentifierDescription
HGNCHGNC:11283Approved symbol: SRC
HGNC NameSRC proto-oncogene, non-receptor tyrosine kinaseOfficial full name
Ensembl GeneENSG00000197122Human gene (GRCh38)
NCBI Entrez6714Gene ID
OMIM190090Gene/locus entry
Genomic Location (GRCh38/hg38)
AttributeValue
Chromosome20
Start Position37,344,673
End Position37,406,050
Strand+ (positive)
Cytoband20q11.23
Gene Length61,378 bp
Biotypeprotein_coding
Additional Gene Attributes
AttributeValue
Locus Typegene with protein product
Gene GroupsSH2 domain containing; Src family tyrosine kinases
Previous SymbolsSRC1
AliasesASV, c-src
StatusApproved

Section 2: Transcript Identifiers Ensembl Transcripts Total Transcript Count: 29

Transcript IDBiotypeStartEndNotes
ENST00000373578protein_coding37,346,14037,406,050Major transcript
ENST00000358208protein_coding37,384,15037,406,050
ENST00000373558protein_coding37,384,15037,406,050
ENST00000373567protein_coding37,383,66837,406,050
ENST00000692112protein_coding37,346,10937,406,050
ENST00000692423protein_coding37,346,14037,406,050
ENST00000693012protein_coding37,346,14037,387,801
ENST00000876226protein_coding37,344,67337,405,431
ENST00000876227protein_coding37,344,68137,405,429
ENST00000876228protein_coding37,344,71437,405,418
ENST00000876229protein_coding37,344,71837,405,415
ENST00000876230protein_coding37,345,10837,405,414
ENST00000876231protein_coding37,345,13837,405,432
ENST00000876232protein_coding37,345,21337,405,418
ENST00000876233protein_coding37,345,93637,405,418
ENST00000876234protein_coding37,346,12537,405,415
ENST00000876235protein_coding37,346,14037,405,415
ENST00000876236protein_coding37,346,14037,404,632
ENST00000876237protein_coding37,383,89937,405,420
ENST00000921683protein_coding37,345,71137,405,415
ENST00000921684protein_coding37,346,32437,405,415
ENST00000950593protein_coding37,383,59637,405,416
ENST00000467556retained_intron37,400,14937,401,957
ENST00000472968retained_intron37,384,32337,394,174
ENST00000489153retained_intron37,393,74537,397,746
ENST00000493775retained_intron37,402,31337,403,031
ENST00000477066CDS_not_defined37,396,42637,405,422
ENST00000477475CDS_not_defined37,400,25137,402,292
ENST00000497734CDS_not_defined37,344,68537,382,787
RefSeq Transcripts (Human, Chromosome 20)
AccessionTypeStatusMANE Select
NM_198291mRNAREVIEWED✓ MANE Select
NM_005417mRNAREVIEWED
RefSeq Proteins (Human)
AccessionStatusMANE Select
NP_938033REVIEWED✓ MANE Select
NP_005408REVIEWED
CCDS Identifiers
CCDS ID
CCDS13294
Exon Information (Canonical Transcript ENST00000373578) Total Exon Count: 14
Exon IDStartEndStrand
ENSE0000146094537,346,14037,346,255+
ENSE0000146097437,365,20437,365,277+
ENSE0000179814737,382,61937,382,786+
ENSE0000066187737,384,15037,384,403+
ENSE0000354431937,386,07537,386,174+
ENSE0000066187937,393,89537,393,993+
ENSE0000352334137,394,17437,394,277+
ENSE0000367893637,396,16237,396,311+
ENSE0000351622937,397,69937,397,854+
ENSE0000356476037,400,11537,400,294+
ENSE0000366925537,401,60237,401,678+
ENSE0000354378837,402,43537,402,588+
ENSE0000363819337,402,74937,402,880+
ENSE0000146095537,403,17137,406,050+

Section 3: Protein Identifiers UniProt Accessions

AccessionStatusNameMassLength
P12931✓ Reviewed (Swiss-Prot)Proto-oncogene tyrosine-protein kinase Src59,835 Da536 aa
A0A8I5KYU4Unreviewed (TrEMBL)---
Alternative Names:
  • Proto-oncogene c-Src
  • pp60c-src RefSeq Proteins
AccessionTypeStatusMANE
NP_938033proteinREVIEWED
NP_005408proteinREVIEWED
Protein Domains and Families Total Domain Annotations: 11
InterPro IDNameType
IPR050198Non-receptor_tyrosine_kinasesFamily
IPR000719Prot_kinase_domDomain
IPR000980SH2Domain
IPR001245Ser-Thr/Tyr_kinase_cat_domDomain
IPR001452SH3_domainDomain
IPR020635Tyr_kinase_cat_domDomain
IPR008266Tyr_kinase_ASActive_site
IPR017441Protein_kinase_ATP_BSBinding_site
IPR011009Kinase-like_dom_sfHomologous_superfamily
IPR036028SH3-like_dom_sfHomologous_superfamily
IPR036860SH2_dom_sfHomologous_superfamily

Section 4: Structure Identifiers Experimental Structures (PDB) Total PDB Structure Count: 79

PDB IDMethodResolution (Å)Title
1FMKX-ray1.50Crystal structure of human tyrosine-protein kinase C-SRC
2SRCX-ray1.50Human tyrosine-protein kinase C-SRC with AMP-PNP
7NG7X-ray1.50Src kinase bound to eCF506 trapped in inactive conformation
9OFXX-ray1.45c-Src SH3 domain in H32 space group
1O43X-ray1.50SH2 in complex with RU82129
1O4AX-ray1.50SH2 in complex with RU82197
1O4RX-ray1.50SH2 in complex with RU78783
6C4SX-ray1.50cSrc SH3 Domain in complex with Choline Kinase
8VCFX-ray1.50Superbinder Src SH2 domain
1O42X-ray1.70SH2 in complex with RU81843
4F5BX-ray1.57Triple mutant Src SH2 domain with phosphotyrosine
8VCGX-ray1.61Mutant Src SH2 domain with phosphotyrosine
1A09X-ray2.00C-src (SH2 domain) complexed
1Y57X-ray1.91Unphosphorylated c-Src in complex with inhibitor
1YOJX-ray1.95Src kinase domain
2BDFX-ray2.10Src kinase with inhibitor AP23451
4MXOX-ray2.11Src kinase bound to bosutinib
6E6EX-ray2.15DGY-06-116 covalent inhibitor of SRC kinase
9NS0NMR-Ground state of Src kinase domain
9NS1NMR-Intermediate state of Src kinase domain
1HCSNMR-Human SRC SH2 domain complex
1HCTNMR-Human SRC SH2 domain complex
... and 57 additional structures Predicted Structures (AlphaFold)
Model IDGlobal pLDDTSequence LengthFraction Very High Confidence
P1293184.594,2140.68 (68%)

Section 5: Cross-Species Orthologs Model Organism Orthologs

OrganismGene IDSymbolBiotype
Mouse (Mus musculus)ENSMUSG00000027646Srcprotein_coding
Rat (Rattus norvegicus)ENSRNOG00000009495Srcprotein_coding
Zebrafish (Danio rerio)ENSDARG00000008107srcprotein_coding
Human Paralogs (Src Family and Related Kinases) Total Paralog Count: 32
Gene IDSymbolFamily
ENSG00000010810FYNSrc family
ENSG00000176105YES1Src family
ENSG00000182866LCKSrc family
ENSG00000254087LYNSrc family
ENSG00000101336HCKSrc family
ENSG00000136573BLKSrc family
ENSG00000000938FGRSrc family
ENSG00000111816FRKSrc-related
ENSG00000101213PTK6Src-related
ENSG00000125508SRMSSrc-related
ENSG00000097007ABL1Non-receptor TK
ENSG00000143322ABL2Non-receptor TK
ENSG00000096968JAK2JAK family
ENSG00000162434JAK1JAK family
ENSG00000105639JAK3JAK family
ENSG00000105397TYK2JAK family
ENSG00000169398PTK2Focal adhesion kinase
ENSG00000120899PTK2BFocal adhesion kinase
ENSG00000165025SYKSpleen TK
ENSG00000115085ZAP70Immune signaling

Section 6: Clinical Variants & AI Predictions ClinVar Variant Summary Total Variant Count: 111+

ClassificationCount
Pathogenic1
Likely Pathogenic1
Uncertain Significance (VUS)35+
Likely Benign20+
Benign30+
Benign/Likely Benign5
Not Provided15+
Pathogenic/Likely Pathogenic Variants
ClinVar IDHGVS NotationClassificationCondition
12573NM_198291.3(SRC):c.1591C>T (p.Gln531Ter)PathogenicThrombocytopenia
225689NM_198291.3(SRC):c.1579G>A (p.Glu527Lys)Likely PathogenicThrombocytopenia
Sample VUS Variants (Top 20)
ClinVar IDHGVS NotationClassification
100851c.1200C>G (p.Asn400Lys)Uncertain significance
2234627c.1018G>A (p.Val340Ile)Uncertain significance
2310404c.811C>T (p.Arg271Trp)Uncertain significance
2388133c.475C>T (p.Arg159Trp)Uncertain significance
2475250c.296C>T (p.Thr99Met)Uncertain significance
2477836c.327G>T (p.Glu109Asp)Uncertain significance
2548214c.1439G>A (p.Arg480Gln)Uncertain significance
2572134c.1585C>G (p.Gln529Glu)Uncertain significance
2584809c.919C>T (p.Pro307Ser)Uncertain significance
2614414c.869A>G (p.Asn290Ser)Uncertain significance
2619551c.890T>C (p.Ile297Thr)Uncertain significance
3169832c.529G>T (p.Val177Leu)Uncertain significance
3169833c.871G>T (p.Gly291Cys)Uncertain significance
3252560c.1250_1253del (p.Asn417fs)Uncertain significance
3252895c.1039+5G>CUncertain significance
3322569c.1460C>T (p.Pro487Leu)Uncertain significance
3322570c.1513G>C (p.Glu505Gln)Uncertain significance
3449216c.242C>A (p.Pro81Gln)Uncertain significance
3449217c.100G>C (p.Ala34Pro)Uncertain significance
3764601c.1070C>T (p.Thr357Ile)Uncertain significance
SpliceAI Predictions Total Predicted Splice Variants: 3,484 Top 20 High-Impact Splice Predictions:
VariantGeneEffectDelta Score
20:37346252:CCAG:CSRCdonor_loss0.99
20:37346254:AG:ASRCdonor_loss0.99
20:37346257:T:ASRCdonor_loss0.99
20:37346256:G:GGSRCdonor_gain0.95
20:37346258:GAGC:GSRCdonor_loss0.75
20:37346254:AGGTG:ASRCdonor_gain0.74
20:37346251:CCCAG:CSRCdonor_gain0.73
20:37346252:CCAGG:CSRCdonor_gain0.73
20:37346253:CAGG:CSRCdonor_gain0.73
20:37346255:GGTGA:GSRCdonor_gain0.73
20:37346256:GTGAG:GSRCdonor_gain0.73
20:37346257:T:TTSRCdonor_gain0.73
20:37346258:GAGCG:GSRCdonor_gain0.73
20:37346234:G:GTSRCdonor_gain0.71
20:37346259:AGCGC:ASRCdonor_gain0.71
20:37346228:C:CASRCdonor_gain0.70
20:37346250:GCCCA:GSRCdonor_gain0.70
20:37346232:G:ASRCdonor_gain0.68
20:37346235:C:TSRCdonor_gain0.68
20:37346260:G:CSRCdonor_gain0.67
AlphaMissense Predictions Total Missense Predictions: 3,468 Top 20 Likely Pathogenic Predictions:
VariantProtein ChangeAM ScoreClassification
20:37384169:A:CS6R0.864likely_pathogenic
20:37384171:C:AS6R0.864likely_pathogenic
20:37384171:C:GS6R0.864likely_pathogenic
20:37384174:G:CK7N0.860likely_pathogenic
20:37384174:G:TK7N0.860likely_pathogenic
20:37384157:G:CG2R0.813likely_pathogenic
20:37384168:G:CK5N0.775likely_pathogenic
20:37384168:G:TK5N0.775likely_pathogenic
20:37384172:A:GK7E0.763likely_pathogenic
20:37384180:G:CK9N0.744likely_pathogenic
20:37384180:G:TK9N0.744likely_pathogenic
20:37384173:A:GK7M0.719likely_pathogenic
20:37384166:A:GK5E0.728likely_pathogenic
20:37384173:A:CK7T0.654likely_pathogenic
20:37384179:A:TK9M0.649likely_pathogenic
20:37384158:G:AG2D0.640likely_pathogenic
20:37384187:A:CS12R0.572likely_pathogenic
20:37384189:C:AS12R0.572likely_pathogenic
20:37384189:C:GS12R0.572likely_pathogenic
20:37384160:A:CS3R0.707likely_pathogenic

Section 7: Biological Pathways & Gene Ontology Reactome Pathways Total Pathway Count: 69

Pathway IDPathway NameDisease Pathway
R-HSA-177929Signaling by EGFRNo
R-HSA-1227986Signaling by ERBB2No
R-HSA-354192Integrin signalingNo
R-HSA-354194GRB2:SOS provides linkage to MAPK signaling for IntegrinsNo
R-HSA-372708p130Cas linkage to MAPK signaling for integrinsNo
R-HSA-4420097VEGFA-VEGFR2 PathwayNo
R-HSA-5218921VEGFR2 mediated cell proliferationNo
R-HSA-2682334EPH-Ephrin signalingNo
R-HSA-3928662EPHB-mediated forward signalingNo
R-HSA-3928663EPHA-mediated growth cone collapseNo
R-HSA-8853659RET signalingNo
R-HSA-1433557Signaling by SCF-KITNo
R-HSA-201556Signaling by ALKNo
R-HSA-1257604PIP3 activates AKT signalingNo
R-HSA-5673000RAF activationNo
R-HSA-5674135MAP2K and MAPK activationNo
R-HSA-171007p38MAPK eventsNo
R-HSA-69231Cyclin D associated events in G1No
R-HSA-389356Co-stimulation by CD28No
R-HSA-389513Co-inhibition by CTLA4No
R-HSA-2029481FCGR activationNo
R-HSA-5607764CLEC7A (Dectin-1) signalingNo
R-HSA-30168Platelet activationNo
R-HSA-9009391Extra-nuclear estrogen signalingNo
R-HSA-9620244Long-term potentiationNo
R-HSA-8934903Receptor Mediated MitophagyNo
R-HSA-2219530Constitutive Signaling by Aberrant PI3K in CancerYes
R-HSA-6802946Signaling by moderate kinase activity BRAF mutantsYes
R-HSA-6802948Signaling by high-kinase activity BRAF mutantsYes
R-HSA-6802952Signaling by BRAF and RAF1 fusionsYes
R-HSA-9649948Signaling downstream of RAS mutantsYes
R-HSA-9656223Signaling by RAF1 mutantsYes
R-HSA-8876493InlA-mediated entry of Listeria monocytogenesYes
Gene Ontology Annotations Total GO Annotations: 121 Molecular Function (Top 20)
GO IDTerm
GO:0004672protein kinase activity
GO:0004713protein tyrosine kinase activity
GO:0004715non-membrane spanning protein tyrosine kinase activity
GO:0005524ATP binding
GO:0005102signaling receptor binding
GO:0005178integrin binding
GO:0019899enzyme binding
GO:0020037heme binding
GO:0016004phospholipase activator activity
GO:0030296protein tyrosine kinase activator activity
GO:0030546signaling receptor activator activity
GO:0035255ionotropic glutamate receptor binding
GO:0042169SH2 domain binding
GO:0043274phospholipase binding
GO:0044325transmembrane transporter binding
GO:0045296cadherin binding
GO:0046875ephrin receptor binding
GO:0051117ATPase binding
GO:0051219phosphoprotein binding
GO:0070700BMP receptor binding
Biological Process (Top 20)
GO IDTerm
GO:0007165signal transduction
GO:0007173epidermal growth factor receptor signaling pathway
GO:0007179transforming growth factor beta receptor signaling pathway
GO:0007229integrin-mediated signaling pathway
GO:0018108peptidyl-tyrosine phosphorylation
GO:0030154cell differentiation
GO:0030168platelet activation
GO:0035556intracellular signal transduction
GO:0043066negative regulation of apoptotic process
GO:0048010vascular endothelial growth factor receptor signaling pathway
GO:0048013ephrin receptor signaling pathway
GO:0050900leukocyte migration
GO:0070374positive regulation of ERK1 and ERK2 cascade
GO:0051897positive regulation of PI3K/AKT signal transduction
GO:0010634positive regulation of epithelial cell migration
GO:0034446substrate adhesion-dependent cell spreading
GO:0048041focal adhesion assembly
GO:0045747positive regulation of Notch signaling pathway
GO:0090263positive regulation of canonical Wnt signaling pathway
GO:2000811negative regulation of anoikis
Cellular Component (Top 20)
GO IDTerm
GO:0005634nucleus
GO:0005737cytoplasm
GO:0005739mitochondrion
GO:0005743mitochondrial inner membrane
GO:0005764lysosome
GO:0005770late endosome
GO:0005829cytosol
GO:0005884actin filament
GO:0005886plasma membrane
GO:0005901caveola
GO:0005911cell-cell junction
GO:0005925focal adhesion
GO:0002102podosome
GO:0030054cell junction
GO:0032587ruffle membrane
GO:0045121membrane raft
GO:0048471perinuclear region of cytoplasm
GO:0070062extracellular exosome

Section 8: Protein Interactions & Molecular Networks STRING Protein-Protein Interactions Total Interaction Count: 9,720+ Top 50 High-Confidence Interactors (Score ≥970):

UniProt IDScoreProtein Name
P49023998Paxillin
P56945998BCAR1 (p130Cas)
Q14247997Cortactin (CTTN)
P03372996Estrogen receptor alpha (ESR1)
P40763996STAT3
Q9Y490996Talin-1 (TLN1)
P18206995Vinculin
P46108995CRK
P49407995β-Arrestin-1
P07900994HSP90AA1
P14317994FLII
Q03135994Caveolin-1
Q9Y4G6994TLN2
P08238993HSP90AB1
P22681993CBL
Q9Y4K3991TNK2
P29353990SHC1
P32121989β-Arrestin-2
P00533988EGFR
Q05397988PTK2 (FAK)
Q14289987PTK2B (PYK2)
P29354986SHC2
P35222986β-Catenin
P13931983Glycogen synthase kinase-3β
P25388983RRAS2
P04626980ERBB2
Q06124980PTPN11 (SHP2)
P31749977AKT1
P43405976SYK
P17302975GJA1
Q9UKG1974ASAP1
P42768973WAS
P05106972Integrin β3
P09619972PDGFRB
P78352964DLG4
Q8N556963AFDN
P35568961IRS1
P08069959IGF1R
P12830955CDH1 (E-cadherin)
Q14185955DOCK1
Q13094953LCP2
Q07666949KHDRBS1
Q9ULH1947ASAP2
P10275944Androgen receptor
Q09472943EP300
P35968938KDR (VEGFR2)
Q14511929NEDD9
P16070926CD44
Q9NP31925SH3PXD2B
P27482923CALM3
IntAct Physical Interactions Total Curated Interactions: 801+ Top 20 High-Confidence Interactions:
PartnerInteraction TypeConfidence
PTK2 (FAK)physical association0.92
ESR1association0.85
KDR (VEGFR2)physical association0.77
LYNassociation0.67
HSP90AA1physical association0.67
MED28physical association0.66
PIK3R3physical association0.62
ARRB1physical association0.62
ASAP1physical association0.61
PECAM1direct interaction0.59
ABL1physical association0.59
ARRB2physical association0.56
CTNNB1phosphorylation0.54
HK1physical association0.52
STAT3enzymatic reaction0.44
BCAR1enzymatic reaction0.44
CDKN1Bphosphorylation reaction0.44
TXNIPdirect interaction0.44
CTTNphosphorylation reaction0.44
SHC1phosphorylation reaction0.44
Structural Similarity (ESM2) Total Similar Proteins: 70 Top 20 Structurally Similar Proteins:
UniProt IDTop SimilarityAvg SimilarityProtein
P062411.00000.9955Fyn proto-oncogene
Q628441.00000.9956Src (mouse)
A1Y2K11.00000.9956Src homolog
P396881.00000.9955Src family kinase
P054800.99990.9949Src (chicken)
P062400.99990.9933LCK
Q016210.99990.9933Src-family kinase
Q047360.99980.9943YES1
P631850.99980.9948Src homolog
P505450.99980.9928Tyrosine kinase
P062390.99970.9928LCK (human)
Q5PXS10.99970.9936Src-family kinase
Q95KR70.99970.9936Src homolog
P079470.99960.9943YES proto-oncogene
P079480.99960.9906LYN
P131150.99960.9952Src-family kinase
P131160.99960.9940Src-family kinase
F1RDG90.99950.9952Src homolog
P005230.99940.9957v-Src (viral)
P142340.99940.9943Src-family kinase
Sequence Homology (DIAMOND) Total Homologous Proteins: 273+ Top 20 by Identity:
UniProt IDIdentity (%)BitscoreProtein
P00523100.01068v-Src viral oncogene
P15054100.01067PP60-SRC
P04049100.01303RAF proto-oncogene
P10533100.0720Src family
A0JNB099.61114SRC homolog
P0624199.61114FYN
P0548099.41077c-Src (Gallus)
A1Y2K199.41115SRC homolog
O1519799.32024Ephrin B3
P0051999.31866ABL1
P0624099.21056LCK
P1408499.61065Src homolog
P1408599.81057Src homolog
P0052499.01060v-Src
P0052599.01060v-Src
P0052699.01061v-Src
P0052798.91048pp60v-src
P0932498.91046Src-related
P0052098.91871ABL proto-oncogene
O0864498.42010Ephrin type-B

Section 9: Transcription Factor Regulatory Data Upstream Regulators (TFs that regulate SRC) Total Regulatory TFs: 32

TF GeneRegulationConfidence
JUNActivationHigh
HNF1AActivationHigh
SP1UnknownHigh
GTF2I-High
JDP2-High
SP3-High
AR-High
ESR1UnknownHigh
AP1ActivationLow
EGR1-Low
FOXO3-Low
HIF1A-Low
HNF4A-Low
NCOA1-Low
NCOA2-Low
NCOA3ActivationLow
NFATC1ActivationLow
NFKB-Low
RBPJActivationLow
RELA-Low
RELB-Low
STAT5A-Low
THRA-Low
ARNT-Low
ESR2-Low
HHEX-Low
IER2-Low
JUNB-Low
KAT7-Low
MAFB-Low
NFIC-Low
TAF1Unknown-
SRC as Kinase: Downstream Signaling Targets Total SIGNOR Entries: 560+ Top 50 Phosphorylation Substrates:
TargetEffectMechanismScore
BCAR1up-regulates activityphosphorylation0.80
CTNNB1up-regulates activityphosphorylation0.76
CTNNB1down-regulates activityphosphorylation0.76
CAV1down-regulates activityphosphorylation0.76
STAT5Aup-regulatesphosphorylation0.75
PTPRAup-regulates activityphosphorylation0.74
CDC42up-regulatesphosphorylation0.69
ARRB1down-regulatesphosphorylation0.68
CAV2down-regulatesphosphorylation0.68
RAPGEF1up-regulatesphosphorylation0.67
TIAM1up-regulatesphosphorylation0.66
PTK2up-regulatesphosphorylation0.65
EZRup-regulatesphosphorylation0.65
SH3GL1down-regulatesphosphorylation0.64
PTK2Bup-regulatesphosphorylation0.62
RAC1up-regulatesphosphorylation0.61
HSP90AB1up-regulatesphosphorylation0.59
GJA1down-regulatesphosphorylation0.59
RRASdown-regulates activityphosphorylation0.58
PDPK1up-regulates activityphosphorylation0.58
CDH5up-regulatesphosphorylation0.57
SPRY2up-regulatesphosphorylation0.56
ANXA2up-regulatesphosphorylation0.55
DAG1down-regulatesphosphorylation0.55
PTENdown-regulatesphosphorylation0.54
CBLCup-regulatesphosphorylation0.54
PRKCIup-regulatesphosphorylation0.53
PTPN6up-regulatesphosphorylation0.53
FLT4up-regulatesphosphorylation0.51
CDKN1Bdown-regulatesphosphorylation0.50
WWOXup-regulatesphosphorylation0.48
PLSCR1up-regulates activityphosphorylation0.48
MPZL1up-regulatesphosphorylation0.47
DGKAup-regulatesphosphorylation0.46
CASP8down-regulatesphosphorylation0.45
MMP14unknownphosphorylation0.43
TERTdown-regulatesphosphorylation0.42
WASF1up-regulatesphosphorylation0.41
NOXA1up-regulatesphosphorylation0.41
PRKD1up-regulatesphosphorylation0.41
ARHGDIAdown-regulatesphosphorylation0.40
CDH2down-regulatesphosphorylation0.40
LRP1up-regulates activityphosphorylation0.39
KITup-regulates activityphosphorylation0.39
DDR2up-regulatesphosphorylation0.38
HCN4up-regulatesphosphorylation0.37
IKBKBup-regulates activityphosphorylation0.36
RPS6KA3up-regulatesphosphorylation0.35
VAV3up-regulatesphosphorylation0.33
FBXO5up-regulatesphosphorylation0.32

Section 10: Drug & Pharmacology Data ChEMBL Target Information

ChEMBL IDTypeDescription
CHEMBL267SINGLE PROTEINProto-oncogene tyrosine-protein kinase Src
CHEMBL2363074PROTEIN FAMILYSRC
CHEMBL2111336SELECTIVITY GROUPVEGF-receptor 2 and tyrosine-protein kinase SRC
CHEMBL4523978SELECTIVITY GROUPSrc/Lck kinase
CHEMBL3885535PROTEIN-PROTEIN INTERACTIONCalmodulin/SRC
CHEMBL4523733PROTEIN-PROTEIN INTERACTIONVHL/SRC
CHEMBL4630728PROTEIN-PROTEIN INTERACTIONCereblon/SRC
FDA-Approved Drugs Targeting SRC (Phase 4)
ChEMBL IDDrug NameTypePhase
CHEMBL1421/CHEMBL5416410DASATINIBSmall molecule4
CHEMBL288441BOSUTINIBSmall molecule4
CHEMBL255863NILOTINIBSmall molecule4
CHEMBL941IMATINIBSmall molecule4
CHEMBL1336SORAFENIBSmall molecule4
CHEMBL535SUNITINIBSmall molecule4
CHEMBL477772PAZOPANIBSmall molecule4
CHEMBL24828VANDETANIBSmall molecule4
CHEMBL939GEFITINIBSmall molecule4
CHEMBL553ERLOTINIBSmall molecule4
CHEMBL554LAPATINIBSmall molecule4
CHEMBL1173655AFATINIBSmall molecule4
CHEMBL180022NERATINIBSmall molecule4
CHEMBL2110732DACOMITINIBSmall molecule4
CHEMBL1873475IBRUTINIBSmall molecule4
CHEMBL2403108CERITINIBSmall molecule4
CHEMBL3545311BRIGATINIBSmall molecule4
CHEMBL1983268ENTRECTINIBSmall molecule4
CHEMBL4298138REPOTRECTINIBSmall molecule4
CHEMBL601719CRIZOTINIBSmall molecule4
CHEMBL2105717CABOZANTINIBSmall molecule4
CHEMBL1171837PONATINIBSmall molecule4
CHEMBL608533MIDOSTAURINSmall molecule4
CHEMBL502835NINTEDANIBSmall molecule4
CHEMBL1287853FEDRATINIBSmall molecule4
CHEMBL1289494TIVOZANIBSmall molecule4
CHEMBL1834657/1852688INFIGRATINIBSmall molecule4
CHEMBL571546TIRBANIBULINSmall molecule4
CHEMBL1448NICLOSAMIDESmall molecule4
Phase 3 Clinical Candidates
ChEMBL IDDrug NameTypePhase
CHEMBL217092SARACATINIBSmall molecule3
CHEMBL1908391MASITINIBSmall molecule3
CHEMBL223360LINIFANIBSmall molecule3
CHEMBL31965CANERTINIBSmall molecule3
CHEMBL3544983TESEVATINIBSmall molecule3
CHEMBL377300BRIVANIBSmall molecule3
CHEMBL428690ALVOCIDIBSmall molecule3
CHEMBL483158ALISERTIBSmall molecule3
CHEMBL491473CEDIRANIBSmall molecule3
CHEMBL50QUERCETINSmall molecule3
CHEMBL522892DOVITINIBSmall molecule3
CHEMBL276711SEMAXANIBSmall molecule3
CHEMBL599552INDIGOSmall molecule3
CHEMBL603469LESTAURTINIBSmall molecule3
CHEMBL103667DORAMAPIMODSmall molecule2
PharmGKB Pharmacogenomics Entry
AttributeValue
PharmGKB IDPA36111
Gene SymbolSRC
VIP GeneYes
Has CPIC GuidelineNo
Chromosomechr20
BindingDB Compounds Total Binding Compounds: 4,955+ Examples of high-affinity SRC inhibitors with IC50 data available.

Section 11: Expression Profiles Bgee Gene Expression Summary

AttributeValue
Expression BreadthUbiquitous
Total Present Calls236
Total Absent Calls50
Total Conditions Tested286
Max Expression Score95.98
Average Expression Score81.10
Gold Quality Annotations242
Top 30 Expressing Tissues
RankTissueScoreQuality
1Body of stomach95.98Gold
2Gall bladder95.89Gold
3Rectum95.58Gold
4Body of pancreas95.45Gold
5Lower esophagus mucosa95.36Gold
6Transverse colon95.11Gold
7Ganglionic eminence94.92Gold
8Cortical plate94.65Gold
9Stomach94.25Gold
10Ectocervix94.18Gold
11Small intestine Peyer's patch94.16Gold
12Body of uterus93.98Gold
13Muscle layer of sigmoid colon93.83Gold
14Mucosa of transverse colon93.62Gold
15Mucosa of stomach93.52Gold
16Ascending aorta93.25Gold
17Small intestine93.15Gold
18Thoracic aorta93.12Gold
19Right testis92.96Gold
20Endocervix92.93Gold
21Esophagus mucosa92.91Gold
22Ventricular zone92.88Gold
23Metanephros cortex92.86Gold
24Left testis92.75Gold
25Right adrenal gland cortex92.73Gold
26Right adrenal gland92.60Gold
27Right ovary92.56Gold
28Left uterine tube92.48Gold
29Left adrenal gland92.48Gold
30Left adrenal gland cortex92.40Gold
Single-Cell Expression Data
Dataset IDDescriptionSpeciesCells
E-HCAD-29GM-CSF-producing T helper cellsHomo sapiens78,686

Section 12: Disease Associations Mendelian Disease Links (GenCC)

DiseaseClassificationInheritanceSource
Thrombocytopenia 6 (OMIM:616937)StrongAutosomal dominantPanelApp Australia
Thrombocytopenia 6 (OMIM:616937)LimitedAutosomal dominantLabcorp Genetics
Thrombocytopenia 6 (Orphanet:480851)SupportiveAutosomal dominantOrphanet
Colorectal cancer (OMIM:114500)No Known Disease RelationshipUnknownLabcorp Genetics
Orphanet Disease Entry
Orphanet IDDisease NameTypeGene Count
480851Hereditary thrombocytopenia with early-onset myelofibrosisDisease1
HPO Phenotype Associations Total Associated Phenotypes: 17
HPO IDPhenotype
HP:0000006Autosomal dominant inheritance
HP:0001442Typified by somatic mosaicism
HP:0001873Thrombocytopenia
HP:0001892Abnormal bleeding
HP:0004406Spontaneous, recurrent epistaxis
HP:0011974Myelofibrosis
HP:0031020Bone marrow hypercellularity
HP:0000939Osteoporosis
HP:0000490Deeply set eye
HP:0000601Hypotelorism
HP:0002003Large forehead
HP:0003003Colon cancer
HP:0005584Renal cell carcinoma
HP:0006716Hereditary nonpolyposis colorectal carcinoma
HP:0006740Transitional cell carcinoma of the bladder
HP:0006753Neoplasm of the stomach
HP:0002891Uterine leiomyosarcoma
GWAS Associations
Study IDTrait/DiseaseP-valueMapped Genes
GCST007843Rheumatoid arthritis4.0e-13SRC - RPL7AP14
GCST003422Squamous cell carcinoma1.0e-06SRC
GCST001854Retinopathy in non-diabetics4.0e-06SRC - RPL7AP14
GCST012488L1-L4 bone mineral density x serum urate interaction3.0e-06SRC

SUMMARY STATISTICS

CategoryCount
Gene Identifiers5 databases
Transcripts (Ensembl)29
RefSeq mRNAs (Human)2 (reviewed)
CCDS IDs1
Exons (canonical)14
UniProt Accessions2
Protein Domains (InterPro)11
PDB Structures79
Orthologs3 (key model organisms)
Paralogs32
ClinVar Variants111+
SpliceAI Predictions3,484
AlphaMissense Predictions3,468
Reactome Pathways69
GO Annotations121
STRING Interactions9,720+
IntAct Interactions801+
SIGNOR Signaling Entries560+
Regulatory TFs32
Approved Drugs (Phase 4)29
Phase 3 Candidates15
BindingDB Compounds4,955+
Expression Tissues236 (ubiquitous)
HPO Phenotypes17
GWAS Associations4

Reference compiled from BioBTree integrated biological databases. Data current as of database version.